Metabolomic profiling predicts outcome of rituximab therapy in rheumatoid arthritis

Objective: To determine whether characterisation of patients' metabolic profiles, utilising nuclear magnetic resonance (NMR) and mass spectrometry (MS), could predict response to rituximab therapy. 23 patients with active, seropositive rheumatoid arthritis (RA) on concomitant methotrexate were...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:RMD Open
Egile Nagusiak: Sweeney, Shannon R, Kavanaugh, Arthur, Lodi, Alessia, Wang, Bo, Boyle, David, Tiziani, Stefano, Guma, Monica
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Publishing Group 2016
Gaiak:
Rheumatoid Arthritis
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5013418/
https://ncbi.nlm.nih.gov/pubmed/27651926
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2016-000289
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak